# Sentinel Lymph Node Mapping Post-Injection Site Pain

> **NCT02065232** · — · COMPLETED · sponsor: **University of California, San Diego** · enrollment: 52 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Tilmanocept
- **DRUG:** Sulfur Colloid

## Key facts

- **NCT ID:** NCT02065232
- **Lead sponsor:** University of California, San Diego
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03
- **Primary completion:** 2015-02
- **Final completion:** 2015-02
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2019-08-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02065232

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02065232, "Sentinel Lymph Node Mapping Post-Injection Site Pain". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02065232. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*